APA (7th ed.) Citation

SS, W., PY, H., TY, Y., PJ, L., JW, C., & CW, Y. (2026). GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Journal of medicinal chemistry, 69(9), 10122. https://doi.org/10.1021/acs.jmedchem.5c03139

Chicago Style (17th ed.) Citation

SS, Wu, Hung PY, Yeh TY, Lin PJ, Chern JW, and Yu CW. "GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease." Journal of Medicinal Chemistry 69, no. 9 (2026): 10122. https://doi.org/10.1021/acs.jmedchem.5c03139.

MLA (9th ed.) Citation

SS, Wu, et al. "GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease." Journal of Medicinal Chemistry, vol. 69, no. 9, 2026, p. 10122, https://doi.org/10.1021/acs.jmedchem.5c03139.